{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T12:31:33Z","timestamp":1717417893425},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T00:00:00Z","timestamp":1494892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s10103-017-2211-0","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T18:38:24Z","timestamp":1494959904000},"page":"1089-1095","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Variability of high-dose melphalan exposure on oral mucositis in patients undergoing prophylactic low-level laser therapy"],"prefix":"10.1007","volume":"32","author":[{"given":"Gustavo Henrique","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziella Chagas","family":"Jaguar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio Abreu","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Guollo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa Oliveira","family":"Camandoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline Santos","family":"Damascena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladmir Claudio Cordeiro","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,16]]},"reference":[{"key":"2211_CR1","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMct0805626","volume":"360","author":"JL Harousseau","year":"2009","unstructured":"Harousseau JL, Moreau P (2009) Autologous hematopoietic stem-cell transplantation for multiple myeloma. N Engl J Med 360:2645\u20132654","journal-title":"N Engl J Med"},{"key":"2211_CR2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0140-6736(09)60221-X","volume":"374","author":"MS Raab","year":"2009","unstructured":"Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC (2009) Multiple myeloma. Lancet 374:324\u2013339","journal-title":"Lancet"},{"key":"2211_CR3","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2007.13.6028","volume":"26","author":"N Blijlevens","year":"2008","unstructured":"Blijlevens N, Schwenkglenks M, Bacon P, D'Addio A, Einsele H et al (2008) Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy\u2014European Blood and Marrow Transplantation Mucositis Advisory Group. J Clin Oncol 26:1519\u20131525","journal-title":"J Clin Oncol"},{"key":"2211_CR4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.bmt.1705471","volume":"38","author":"ML Grazziutti","year":"2006","unstructured":"Grazziutti ML, Dong L, Miceli MH, Krishna SG, Kiwan E et al (2006) Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model. Bone Marrow Transplant 38:501\u2013506","journal-title":"Bone Marrow Transplant"},{"key":"2211_CR5","first-page":"231","volume":"5","author":"M Vera-Llonch","year":"2007","unstructured":"Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S (2007) Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma. J Support Oncol 5:231\u2013235","journal-title":"J Support Oncol"},{"key":"2211_CR6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0609.2005.00446.x","volume":"75","author":"LM Knudsen","year":"2005","unstructured":"Knudsen LM, Nielsen B, Gimsing P, Geisler C (2005) Autologous stem cell transplantation in multiple myeloma: outcome in patients with renal failure. Eur J Haematol 75:27\u201333","journal-title":"Eur J Haematol"},{"key":"2211_CR7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1182\/blood.V99.3.731","volume":"99","author":"P Moreau","year":"2002","unstructured":"Moreau P, Facon T, Attal M, Hulin C, Michallet M et al (2002) Comparison of 200 mg\/m(2) melphalan and 8 Gy total body irradiation plus 140 mg\/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du My\u00e9lome 9502 randomized trial. Blood 99:731\u2013735","journal-title":"Blood"},{"key":"2211_CR8","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.20162","volume":"100","author":"ST Sonis","year":"2004","unstructured":"Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M et al (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100:1995\u20132025","journal-title":"Cancer"},{"key":"2211_CR9","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1601-0825.2006.01330.x","volume":"13","author":"GC Jaguar","year":"2007","unstructured":"Jaguar GC, Prado JD, Nishimoto IN, Pinheiro MC, de Castro DO Jr et al (2007) Low-energy laser therapy for prevention of oral mucositis in hematopoietic stem cell transplantation. Oral Dis 13:538\u2013543","journal-title":"Oral Dis"},{"key":"2211_CR10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/bmt.2008.299","volume":"43","author":"S McCann","year":"2009","unstructured":"McCann S, Schwenkglenks M, Bacon P, Einsele H, D'Addio A et al (2009) The prospective oral mucositis audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT. Bone Marrow Transplant 43:141\u2013147","journal-title":"Bone Marrow Transplant"},{"key":"2211_CR11","first-page":"1767","volume":"17","author":"JB Epstein","year":"2003","unstructured":"Epstein JB, Schubert MM (2003) Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, and management. Oncology 17:1767\u20131779","journal-title":"Oncology"},{"key":"2211_CR12","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00520-007-0238-7","volume":"15","author":"MM Schubert","year":"2007","unstructured":"Schubert MM, Eduardo FP, Guthrie KA, Franquin JC, Bensadoun RJ et al (2007) A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation. Support Care Cancer 15:1145\u20131154","journal-title":"Support Care Cancer"},{"key":"2211_CR13","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1056\/NEJMoa040125","volume":"351","author":"R Spielberger","year":"2004","unstructured":"Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D et al (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351:2590\u20132598","journal-title":"N Engl J Med"},{"key":"2211_CR14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/annonc\/mdl332","volume":"18","author":"N Blijlevens","year":"2007","unstructured":"Blijlevens N, Sonis S (2007) Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy and radiotherapy-induced mucositis. Ann Oncol 18:817\u2013826","journal-title":"Ann Oncol"},{"issue":"9","key":"2211_CR15","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/annonc\/mdq059","volume":"21","author":"G Kobbe","year":"2010","unstructured":"Kobbe G, Bruns I, Schroeder T, Czibere A, Warnecke J et al (2010) A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myeloma. Ann Oncol 21(9):1898\u20131904","journal-title":"Ann Oncol"},{"issue":"6","key":"2211_CR16","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.bbmt.2014.02.025","volume":"20","author":"AK Nooka","year":"2014","unstructured":"Nooka AK, Johnson HR, Kaufman JL, Flowers CR, Langston A et al (2014) Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20(6):852\u2013857","journal-title":"Biol Blood Marrow Transplant"},{"key":"2211_CR17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0360-3016(97)00076-X","volume":"38","author":"D Cowen","year":"1997","unstructured":"Cowen D, Tardieu C, Schubert M, Peterson D, Resbeut M et al (1997) Low energy helium-neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial. Int J Radiat Oncol Biol Phys 38:697\u2013703","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2211_CR18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/pho.2009.2699","volume":"29","author":"GB Silva","year":"2011","unstructured":"Silva GB, Mendon\u00e7a EF, Bariani C, Antunes HS, Silva MA (2011) The prevention of induced oral mucositis with low-level laser therapy in bone marrow transplantation patients: a randomized clinical trial. Photomed Laser Surg 29:27\u201331","journal-title":"Photomed Laser Surg"},{"key":"2211_CR19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00520-012-1605-6","volume":"21","author":"C Migliorati","year":"2013","unstructured":"Migliorati C, Hewson I, Lalla RV, Antunes HS, Estilo CL et al (2013) Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support Care Cancer 21:333\u2013341","journal-title":"Support Care Cancer"},{"key":"2211_CR20","first-page":"1493","volume":"20","author":"DB McGuire","year":"1993","unstructured":"McGuire DB, Altomonte V, Peterson DE, Wingard JR, Jones RJ et al (1993) Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation. Oncol Nurs Forum 20:1493\u20131502","journal-title":"Oncol Nurs Forum"},{"key":"2211_CR21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpainsymman.2011.08.012","volume":"44","author":"P Salvador","year":"2012","unstructured":"Salvador P, Azusano C, Wang L, Howell D (2012) A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. J Pain Symptom Manag 44:64\u201373","journal-title":"J Pain Symptom Manag"},{"key":"2211_CR22","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/1097-0142(19951215)76:12<2550::AID-CNCR2820761222>3.0.CO;2-X","volume":"76","author":"A Barasch","year":"1995","unstructured":"Barasch A, Peterson DE, Tanzer JM, D'Ambrosio JA, Nuki K et al (1995) Helium-neon laser effects on conditioning-induced oral mucositis in bone marrow transplantation patients. Cancer 76:2550\u20132556","journal-title":"Cancer"},{"key":"2211_CR23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1368-8375(97)00065-1","volume":"34","author":"W Parulekar","year":"1998","unstructured":"Parulekar W, Mackenzie R, Bjarnason G, Jordan RC (1998) Scoring oral mucositis. Oral Oncol 34:63\u201371","journal-title":"Oral Oncol"},{"key":"2211_CR24","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1182\/blood-2003-02-0444","volume":"102","author":"RK Dasgupta","year":"2003","unstructured":"Dasgupta RK, Adamson PJ, Davies FE, Rollinson S, Roddam PL et al (2003) Polymorphic variation in GSTP1 modulates outcome following therapy for multiple myeloma. Blood 102:2345\u20132350","journal-title":"Blood"},{"key":"2211_CR25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00130404-200205000-00008","volume":"8","author":"SF Wong","year":"2002","unstructured":"Wong SF, Wilder-Smith P (2002) Pilot study of laser effects on oral mucositis in patients receiving chemotherapy. Cancer J 8:247\u2013254","journal-title":"Cancer J"},{"key":"2211_CR26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hon.2133","volume":"33","author":"F De Paula Eduardo","year":"2015","unstructured":"De Paula Eduardo F, Bezinelli LM, Da Gra\u00e7a Lopes RM, Nascimento Sobrinho JJ, Hamerschlak N et al (2015) Efficacy of cryotherapy associated with laser therapy for decreasing severity of melphalan-induced oral mucositis during hematological stem-cell transplantation: a prospective clinical study. Hematol Oncol 33:152\u2013158","journal-title":"Hematol Oncol"},{"key":"2211_CR27","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00520-009-0603-9","volume":"17","author":"NNF Lopes","year":"2009","unstructured":"Lopes NNF, Plaper M, Chavantes MC, Lalla RV, Yoshimura EM et al (2009) Cyclooxygenase-2 and vascular endothelial factor expression in 5-fluoracil-induced oral mucositis in hamsters: evaluation of two low-intensity laser protocols. Support Care Cancer 17:1409\u20131415","journal-title":"Support Care Cancer"},{"key":"2211_CR28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/pho.2009.2503","volume":"27","author":"CS Enwemeka","year":"2009","unstructured":"Enwemeka CS (2009) Intricacies of dose in laser phototherapy for tissue repair and pain relief. Photomed Laser Surg 27:387\u2013393","journal-title":"Photomed Laser Surg"},{"key":"2211_CR29","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s10103-012-1089-0","volume":"27","author":"CB Cunha","year":"2012","unstructured":"Cunha CB, Eduardo FP, Zezell DM, Bezinelli LM, Shitara PP et al (2012) Effect of irradiation with red and infrared laser in the treatment of oral mucositis: a pilot study with patients undergoing chemotherapy with 5-FU. Lasers Med Sci 27:1233\u20131240","journal-title":"Lasers Med Sci"},{"key":"2211_CR30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10103-014-1624-2","volume":"30","author":"GB Silva","year":"2015","unstructured":"Silva GB, Sacono NT, Othon-Leite AF, Mendon\u00e7a EF, Arantes AM et al (2015) Effect of low-level laser therapy on inflammatory mediator release during chemotherapy-induced oral mucositis: a randomized preliminary study. Lasers Med Sci 30:117\u2013126","journal-title":"Lasers Med Sci"},{"issue":"1","key":"2211_CR31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00520-012-1605-6","volume":"21","author":"C Migliorati","year":"2013","unstructured":"Migliorati C, Hewson I, Lalla RV, Antunes HS, Estilo CL et al (2013) Mucositis Study Group of the Multinational Association of Supportive Care in Cancer\/International Society of Oral Oncology (MASCC\/ISOO). Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support Care Cancer 21(1):333\u2013341","journal-title":"Support Care Cancer"},{"key":"2211_CR32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/pho.2007.2225","volume":"27","author":"FP Eduardo","year":"2009","unstructured":"Eduardo FP, Bezinelli L, Luiz AC, Correa L, Vogel C et al (2009) Severity of oral mucositis in patients undergoing hematopoietic cell transplantation and an oral laser phototherapy protocol: a survey of 30 patients. Photomed Laser Surg 27:137\u2013144","journal-title":"Photomed Laser Surg"},{"key":"2211_CR33","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1182\/blood-2006-07-035022","volume":"109","author":"HS Antunes","year":"2007","unstructured":"Antunes HS, de Azevedo AM, da Silva Bouzas LF et al (2007) Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial. Blood 109:2250\u20132255","journal-title":"Blood"},{"key":"2211_CR34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1034\/j.1600-0609.2000.90221.x","volume":"65","author":"LM Knudsen","year":"2000","unstructured":"Knudsen LM, Hjorth M, Hippe E (2000) Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group. Eur J Haematol 65:175\u2013181","journal-title":"Eur J Haematol"},{"key":"2211_CR35","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.bbmt.2009.03.021","volume":"15","author":"GC Parikh","year":"2009","unstructured":"Parikh GC, Amjad AI, Saliba RM, Kazmi SM, Khan ZU et al (2009) Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma. Biol Blood Marrow Transplant 15:812\u2013816","journal-title":"Biol Blood Marrow Transplant"},{"key":"2211_CR36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.bmt.1705627","volume":"39","author":"MA Gertz","year":"2007","unstructured":"Gertz MA, Lacy MQ, Dispenzieri A, Hayman SR, Kumar S et al (2007) Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma. Bone Marrow Transplant 39:605\u2013611","journal-title":"Bone Marrow Transplant"},{"key":"2211_CR37","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/ndt\/15.3.301","volume":"15","author":"H Goldschmidt","year":"2000","unstructured":"Goldschmidt H, Lannert H, Bommer J, Ho AD (2000) Multiple myeloma and renal failure. Nephrol Dial Transplant 15:301\u2013304","journal-title":"Nephrol Dial Transplant"},{"key":"2211_CR38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1054\/bjoc.2001.1928","volume":"85","author":"B Sirohi","year":"2011","unstructured":"Sirohi B, Powles R, Kulkarni S, Rudin C, Saso R et al (2011) Glomerular filtration rate prior to high-dose melphalan 200 mg\/m2 as a surrogate marker of outcome in patients with myeloma. Br J Cancer 85:325\u2013332","journal-title":"Br J Cancer"},{"key":"2211_CR39","first-page":"947","volume":"2","author":"G Tricot","year":"1996","unstructured":"Tricot G, Alberts DS, Johnson C, Roe DJ, Dorr RT et al (1996) Safety of autotransplants with high-dose melphalan in renal failure: a pharmacokinetic and toxicity study. Clin Cancer Res 2:947\u2013952","journal-title":"Clin Cancer Res"},{"key":"2211_CR40","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1046\/j.1365-2141.2001.03033.x","volume":"114","author":"A Badros","year":"2001","unstructured":"Badros A, Barlogie B, Siegel E, Roberts J, Langmaid C et al (2001) Results of autologous stem cell transplant in multiple myeloma patients with renal failure. Br J Haematol 114:822\u2013829","journal-title":"Br J Haematol"},{"key":"2211_CR41","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1080\/1042819031000119262","volume":"44","author":"GH Lyman","year":"2003","unstructured":"Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ et al (2003) Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy. Leuk Lymphoma 44:2069\u20132076","journal-title":"Leuk Lymphoma"},{"key":"2211_CR42","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.21847","volume":"106","author":"NM Kuderer","year":"2006","unstructured":"Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106:2258\u20132266","journal-title":"Cancer"},{"issue":"10","key":"2211_CR43","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.bmt.1705360","volume":"37","author":"E Jantunen","year":"2006","unstructured":"Jantunen E, Kuittinen T, Penttil\u00e4 K, Lehtonen P, Mahlam\u00e4ki E et al (2006) High-dose melphalan (200 mg\/m2) supported by autologous stem cell transplantation is safe and effective in elderly (>or=65 years) myeloma patients: comparison with younger patients treated on the same protocol. Bone Marrow Transplant 37(10):917\u2013922","journal-title":"Bone Marrow Transplant"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10103-017-2211-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-017-2211-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-017-2211-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T09:32:29Z","timestamp":1497346349000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10103-017-2211-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,16]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["2211"],"URL":"https:\/\/doi.org\/10.1007\/s10103-017-2211-0","relation":{},"ISSN":["0268-8921","1435-604X"],"issn-type":[{"value":"0268-8921","type":"print"},{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,16]]}}}